1
|
Hushpulian DM, Kaidery NA, Dutta D, Sharma SM, Gazaryan I, Thomas B. Emerging small molecule inhibitors of Bach1 as therapeutic agents: Rationale, recent advances, and future perspectives. Bioessays 2024; 46:e2300176. [PMID: 37919861 DOI: 10.1002/bies.202300176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 10/18/2023] [Accepted: 10/24/2023] [Indexed: 11/04/2023]
Abstract
The transcription factor Nrf2 is the master regulator of cellular stress response, facilitating the expression of cytoprotective genes, including those responsible for drug detoxification, immunomodulation, and iron metabolism. FDA-approved Nrf2 activators, Tecfidera and Skyclarys for patients with multiple sclerosis and Friedreich's ataxia, respectively, are non-specific alkylating agents exerting side effects. Nrf2 is under feedback regulation through its target gene, transcriptional repressor Bach1. Specifically, in Parkinson's disease and other neurodegenerative diseases with Bach1 dysregulation, excessive Bach1 accumulation interferes with Nrf2 activation. Bach1 is a heme sensor protein, which, upon heme binding, is targeted for proteasomal degradation, relieving the repression of Nrf2 target genes. Ideally, a combination of Nrf2 stabilization and Bach1 inhibition is necessary to achieve the full therapeutic benefits of Nrf2 activation. Here, we discuss recent advances and future perspectives in developing small molecule inhibitors of Bach1, highlighting the significance of the Bach1/Nrf2 signaling pathway as a promising neurotherapeutic strategy.
Collapse
Affiliation(s)
- Dmitry M Hushpulian
- Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, Russia
- A.N. Bach Institute of Biochemistry, Federal Research Center "Fundamentals of Biotechnology" of the Russian Academy of Sciences, Moscow, Russia
| | - Navneet Ammal Kaidery
- Darby Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina, USA
- Departments of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Debashis Dutta
- Darby Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina, USA
- Departments of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Sudarshana M Sharma
- Department of Biochemistry & Molecular Biology and Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Irina Gazaryan
- Department of Chemical Enzymology, M.V. Lomonosov Moscow State University, Moscow, Russia
- Department of Chemistry and Physical Sciences, Dyson College of Arts and Sciences, Pace University, Pleasantville, New York, USA
| | - Bobby Thomas
- Darby Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina, USA
- Departments of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Drug Discovery, Medical University of South Carolina, Charleston, South Carolina, USA
| |
Collapse
|
2
|
Shaposhnikov LA, Chikurova NY, Atroshenko DL, Savin SS, Kleymenov SY, Chernobrovkina AV, Pometun EV, Minyaev ME, Matyuta IO, Hushpulian DM, Boyko KM, Tishkov VI, Pometun AA. Structure-Functional Examination of Novel Ribonucleoside Hydrolase C (RihC) from Limosilactobacillus reuteri LR1. Int J Mol Sci 2023; 25:538. [PMID: 38203708 PMCID: PMC10778931 DOI: 10.3390/ijms25010538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Revised: 12/25/2023] [Accepted: 12/27/2023] [Indexed: 01/12/2024] Open
Abstract
Ribonucleoside hydrolase C (RihC, EC 3.2.2.1, 3.2.2.2, 3.2.2.3, 3.2.2.7, 3.2.2.8) belongs to the family of ribonucleoside hydrolases Rih and catalyzes the cleavage of ribonucleosides to nitrogenous bases and ribose. RihC is one of the enzymes that are synthesized by lactobacilli in response to the presence of Klebsiella. To characterize this protein from Limosilactobacillus reuteri LR1, we cloned and expressed it. The activity of the enzyme was studied towards a wide range of substrates, including ribonucleosides, deoxyribonucleosides as well as an arabinoside. It was shown that the enzyme is active only with ribonucleosides and arabinoside, with the best substrate being uridine. The thermal stability of this enzyme was studied, and its crystal structure was obtained, which demonstrated the tetrameric architecture of the enzyme and allowed to shed light on a correlation between its structure and enzymatic activity. Comprehensive comparisons of all known RihC structures, both existing crystal structures and computed model structures from various species, were made, allowing for the identification of structural motifs important for enzyme functioning.
Collapse
Affiliation(s)
- Leonid A. Shaposhnikov
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1–3, Moscow 119991, Russia;
| | - Natalia Yu. Chikurova
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1–3, Moscow 119991, Russia;
| | - Denis L. Atroshenko
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1–3, Moscow 119991, Russia;
- Institute of Medicine, Peoples’ Friendship University of Russia Named after Patrice Lumumba, Miklouho-Maklaya, 8, Moscow 117198, Russia
| | - Svyatoslav S. Savin
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1–3, Moscow 119991, Russia;
| | - Sergei Yu. Kleymenov
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
- Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova, 26, Moscow 119334, Russia
| | - Alla V. Chernobrovkina
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1–3, Moscow 119991, Russia;
| | - Evgenii V. Pometun
- Department of Analytical, Physical and Colloidal Chemistry, A.P. Nelyubin Institute of Pharmacy, Sechenov First Moscow State Medical University, Trubetskaya St., 8, Building 2, Moscow 119048, Russia;
| | - Mikhail E. Minyaev
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, Leninsky Avenue, 47, Moscow 119991, Russia;
| | - Ilya O. Matyuta
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
| | - Dmitry M. Hushpulian
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
| | - Konstantin M. Boyko
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
| | - Vladimir I. Tishkov
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1–3, Moscow 119991, Russia;
- Faculty of Biology and Biotechnology, National Research University Higher School of Economics, Profsoyuznaya St., 33, Building 4, Moscow 117418, Russia
| | - Anastasia A. Pometun
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninsky Avenue, 33/2, Moscow 119071, Russia; (N.Y.C.); (D.L.A.); (S.S.S.); (S.Y.K.); (I.O.M.); (D.M.H.); (K.M.B.); (V.I.T.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1–3, Moscow 119991, Russia;
- Institute of Medicine, Peoples’ Friendship University of Russia Named after Patrice Lumumba, Miklouho-Maklaya, 8, Moscow 117198, Russia
| |
Collapse
|
3
|
Popov AM, Kozlovskaya EP, Klimovich AA, Rutckova TA, Vakhrushev AI, Hushpulian DM, Gazaryan IG, Makhankov VV, Son OM, Tekutyeva LA. Carotenoids from Starfish Patiria pectinifera: Therapeutic Activity in Models of Inflammatory Diseases. Mar Drugs 2023; 21:470. [PMID: 37755083 PMCID: PMC10533026 DOI: 10.3390/md21090470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Revised: 08/20/2023] [Accepted: 08/25/2023] [Indexed: 09/28/2023] Open
Abstract
The carotenoids mixture (MC) isolated from the starfish Patiria. pectinifera contains more than 50% astaxanthin, 4-6% each zeaxanthine and lutein, and less pharmacologically active components such as free fatty acids and their glycerides. Astaxanthin, the major component of MC, belongs to the xanthophyll class of carotenoids, and is well known for its antioxidant properties. In this work, in vitro and in vivo studies on the biological activity of MC were carried out. The complex was shown to exhibit anti-inflammatory, anti-allergic and cancer-preventive activity, without any toxicity at a dose of 500 mg/kg. MC effectively improves the clinical picture of the disease progressing, as well as normalizing the cytokine profile and the antioxidant defense system in the in vivo animal models of inflammatory diseases, namely: skin carcinogenesis, allergic contact dermatitis (ACD) and systemic inflammation (SI). In the skin carcinogenesis induced by 7,12-dimethylbenzanthracene, the incidence of papillomas was decreased 1.5 times; 1% MC ointment form in allergic contact dermatitis showed an 80% reduced severity of pathomorphological skin manifestations. Obtained results show that MC from starfish P. pectinifera is an effective remedy for the treatment and prevention of inflammatory processes.
Collapse
Affiliation(s)
- Aleksandr M. Popov
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Science, 159 Prospect 100-letiya Vladivostoka, Vladivostok 690022, Russia; (A.A.K.); (T.A.R.); (A.I.V.)
| | - Emma P. Kozlovskaya
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Science, 159 Prospect 100-letiya Vladivostoka, Vladivostok 690022, Russia; (A.A.K.); (T.A.R.); (A.I.V.)
| | - Anna A. Klimovich
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Science, 159 Prospect 100-letiya Vladivostoka, Vladivostok 690022, Russia; (A.A.K.); (T.A.R.); (A.I.V.)
| | - Tatyana A. Rutckova
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Science, 159 Prospect 100-letiya Vladivostoka, Vladivostok 690022, Russia; (A.A.K.); (T.A.R.); (A.I.V.)
| | - Aleksey I. Vakhrushev
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Science, 159 Prospect 100-letiya Vladivostoka, Vladivostok 690022, Russia; (A.A.K.); (T.A.R.); (A.I.V.)
| | - Dmitry M. Hushpulian
- Faculty of Biology and Biotechnology, National Research University Higher School of Economics, 13/4 Myasnitskaya str., Moscow 117997, Russia; (D.M.H.); (I.G.G.)
- Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences, Leninski prospect 33, Moscow 1190721, Russia
| | - Irina G. Gazaryan
- Faculty of Biology and Biotechnology, National Research University Higher School of Economics, 13/4 Myasnitskaya str., Moscow 117997, Russia; (D.M.H.); (I.G.G.)
- Department of Chemical Enzymology, M.V. Lomonosov Moscow State University, Moscow 119991, Russia
- Department of Chemistry and Physical Sciences, Dyson College of Art and Sciences, Pace University, 861 Bedford Road, Pleasantville, NY 10570, USA
| | - Vyacheslav V. Makhankov
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Science, 159 Prospect 100-letiya Vladivostoka, Vladivostok 690022, Russia; (A.A.K.); (T.A.R.); (A.I.V.)
| | - Oksana M. Son
- School of Advanced Engineering Studies, Institute of Biotechnology, Bioengineering and Food Systems, Far Eastern Federal University, p. Ajax 10, Russky Island, Vladivostok 690922, Russia; (O.M.S.); (L.A.T.)
- ARNIKA, Territory of PDA Nadezhdinskaya, Volno-Nadezhdinskoye 692481, Russia
| | - Liudmila A. Tekutyeva
- School of Advanced Engineering Studies, Institute of Biotechnology, Bioengineering and Food Systems, Far Eastern Federal University, p. Ajax 10, Russky Island, Vladivostok 690922, Russia; (O.M.S.); (L.A.T.)
- ARNIKA, Territory of PDA Nadezhdinskaya, Volno-Nadezhdinskoye 692481, Russia
| |
Collapse
|
4
|
Gaisina IN, Hushpulian DM, Gaisin AM, Kazakov EH, Ammal Kaidery N, Ahuja M, Poloznikov AA, Gazaryan IG, Thatcher GRJ, Thomas B. Identification of a potent Nrf2 displacement activator among aspirin-containing prodrugs. Neurochem Int 2021; 149:105148. [PMID: 34329734 DOI: 10.1016/j.neuint.2021.105148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 07/21/2021] [Accepted: 07/26/2021] [Indexed: 11/29/2022]
Abstract
Aspirin is a desired leaving group in prodrugs aimed at treatment of neurodegeneration and other conditions. A library of aspirin derivatives of various scaffolds potentially activating Nrf2 has been tested in Neh2-luc reporter assay which screens for direct Nrf2 protein stabilizers working via disruption of Nrf2-Keap1 interaction. Most aspirin prodrugs had a pro-alkylating or pro-oxidant motif in the structure and, therefore, were toxic at high concentrations. However, among the active compounds, we identified a molecule resembling a well-known Nrf2 displacement activator, bis-1,4-(4-methoxybenzenesulfonamidyl) naphthalene (NMBSA). The direct comparison of the newly identified compound with NMBSA and its improved analog in the reporter assay showed no quenching with N-acetyl cysteine, thus pointing to Nrf2 stabilization mechanism without cysteine alkylation. The potency of the newly identified compound in the reporter assay was much stronger than NMBSA, despite its inhibitory action in the commercial fluorescence polarization assay was observed only in the millimolar range. Molecular docking predicted that mono-deacetylation of the novel prodrug should generate a potent displacement activator. The time-course of reporter activation with the novel prodrug had a pronounced lag-period pointing to a plausible intracellular transformation leading to an active product. Treatment of the novel prodrug with blood plasma or cell lysate demonstrated stepwise deacetylation as judge by liquid chromatography-mass spectrometry (LC-MS). Hence, the esterase-catalyzed hydrolysis of the prodrug liberates only acetyl groups from aspirin moiety and generates a potent Nrf2 activator. The discovered mechanism of prodrug activation makes the newly identified compound a promising lead for future optimization studies.
Collapse
Affiliation(s)
- Irina N Gaisina
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL, USA.
| | - Dmitry M Hushpulian
- Faculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow, Russia
| | - Arsen M Gaisin
- Integrated Molecular Structure Education and Research Center, Northwestern University, Evanston, IL, USA
| | | | - Navneet Ammal Kaidery
- Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC, USA; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA
| | - Manuj Ahuja
- Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC, USA; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA; Department of Pharmaceutical Sciences, University of Buffalo, Buffalo, NY, USA
| | - Andrey A Poloznikov
- Faculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow, Russia
| | - Irina G Gazaryan
- Faculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow, Russia; Department of Chemical Enzymology, M.V.Lomonosov Moscow State University, Moscow, Russia; Department of Chemistry and Physical Sciences, Pace University, Pleasantville, NY, USA
| | - Gregory R J Thatcher
- Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA
| | - Bobby Thomas
- Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC, USA; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA; Department of Drug Discovery, Medical University of South Carolina, Charleston, SC, USA.
| |
Collapse
|
5
|
Ciogli L, Zumpano R, Poloznikov AA, Hushpulian DM, Tishkov VI, Andreu R, Gorton L, Mazzei F, Favero G, Bollella P. Highly Sensitive Hydrogen Peroxide Biosensor Based on Tobacco Peroxidase Immobilized on
p
‐Phenylenediamine Diazonium Cation Grafted Carbon Nanotubes: Preventing Fenton‐like Inactivation at Negative Potential. ChemElectroChem 2021. [DOI: 10.1002/celc.202100341] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Leonardo Ciogli
- Department of Chemistry and Drug Technologies Sapienza University of Rome P.le Aldo Moro 5 00185 Rome Italy
| | - Rosaceleste Zumpano
- Department of Chemistry and Drug Technologies Sapienza University of Rome P.le Aldo Moro 5 00185 Rome Italy
| | - Andrey A. Poloznikov
- Faculty of Biology and Biotechnology National Research University Higher School of Economics 13/4 Myasnitskaya str. Moscow 117997 Russia
| | - Dmitry M. Hushpulian
- Faculty of Biology and Biotechnology National Research University Higher School of Economics 13/4 Myasnitskaya str. Moscow 117997 Russia
| | - Vladimir I. Tishkov
- Bach Institute of Biochemistry Research Center of Biotechnology of the Russian Academy of Sciences Leninsky Prospect 33, bld. 2 Moscow 119071 Russia
- Department of Chemical Enzymology School of Chemistry M.V. Lomonosov Moscow State University Moscow 119991 Russia
| | - Rafael Andreu
- Department of Physical Chemistry University of Sevilla Profesor García González 1 41012 Sevilla Spain
| | - Lo Gorton
- Department of Analytical Chemistry/Biochemistry and Structural Biology Lund University P.O. Box 124 SE-221 00 Lund Sweden
| | - Franco Mazzei
- Department of Chemistry and Drug Technologies Sapienza University of Rome P.le Aldo Moro 5 00185 Rome Italy
| | - Gabriele Favero
- Department of Chemistry and Drug Technologies Sapienza University of Rome P.le Aldo Moro 5 00185 Rome Italy
| | - Paolo Bollella
- Department of Chemistry and Biomolecular Science Clarkson University Potsdam NY 13699-5810 United States
- Department of Chemistry University of Bari A. Moro Via E. Orabona 4 70125 Bari Italy
| |
Collapse
|
6
|
Hushpulian DM, Ammal Kaidery N, Ahuja M, Poloznikov AA, Sharma SM, Gazaryan IG, Thomas B. Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue. Front Aging Neurosci 2021; 13:673205. [PMID: 33897412 PMCID: PMC8060438 DOI: 10.3389/fnagi.2021.673205] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2021] [Accepted: 03/15/2021] [Indexed: 12/30/2022] Open
Abstract
The Keap1-Nrf2 signaling axis is a validated and promising target for cellular defense and survival pathways. This minireview discusses the potential off-target effects and their impact on future drug development originating from Keap1-targeting small molecules that function as displacement activators of the redox-sensitive transcription factor Nrf2. We argue that small-molecule displacement activators, similarly to electrophiles, will release both Nrf2 and other Keap1 client proteins from the ubiquitin ligase complex. This non-specificity is likely unavoidable and may result in off-target effects during Nrf2 activation by targeting Keap1. The small molecule displacement activators may also target Kelch domains in proteins other than Keap1, causing additional off-target effects unless designed to ensure specificity for the Kelch domain only in Keap1. A potentially promising and alternative therapeutic approach to overcome this non-specificity emerging from targeting Keap1 is to inhibit the Nrf2 repressor Bach1 for constitutive activation of the Nrf2 pathway and bypass the Keap1-Nrf2 complex.
Collapse
Affiliation(s)
- Dmitry M. Hushpulian
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia
- Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, Russia
| | - Navneet Ammal Kaidery
- Darby Children’s Research Institute, Medical University of South Carolina, Charleston, SC, United States
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC, United States
| | - Manuj Ahuja
- Darby Children’s Research Institute, Medical University of South Carolina, Charleston, SC, United States
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC, United States
- Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, United States
| | - Andrey A. Poloznikov
- Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, Russia
| | - Sudarshana M. Sharma
- Hollings Cancer Center, Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, United States
| | - Irina G. Gazaryan
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia
- Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, Russia
- Department of Chemical Enzymology, M.V. Lomonosov Moscow State University, Moscow, Russia
- Department of Chemistry and Physical Sciences, Dyson College of Arts and Sciences, Pace University, Pleasantville, NY, United States
| | - Bobby Thomas
- Darby Children’s Research Institute, Medical University of South Carolina, Charleston, SC, United States
- Department of Pediatrics, Medical University of South Carolina, Charleston, SC, United States
- Department of Neuroscience, Medical University of South Carolina, Charleston, SC, United States
- Department of Drug Discovery, Medical University of South Carolina, Charleston, SC, United States
| |
Collapse
|
7
|
Poloznikov AA, Nersisyan SA, Hushpulian DM, Kazakov EH, Tonevitsky AG, Kazakov SV, Vechorko VI, Nikulin SV, Makarova JA, Gazaryan IG. HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons. Front Pharmacol 2021; 11:621054. [PMID: 33584306 PMCID: PMC7878396 DOI: 10.3389/fphar.2020.621054] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Accepted: 12/31/2020] [Indexed: 12/14/2022] Open
Abstract
The review analyzes the potential advantages and problems associated with using HIF prolyl hydroxylase inhibitors as a treatment for COVID-19. HIF prolyl hydroxylase inhibitors are known to boost endogenous erythropoietin (Epo) and activate erythropoiesis by stabilizing and activating the hypoxia inducible factor (HIF). Recombinant Epo treatment has anti-inflammatory and healing properties, and thus, very likely, will be beneficial for moderate to severe cases of COVID-19. However, HIF PHD inhibition may have a significantly broader effect, in addition to stimulating the endogenous Epo production. The analysis of HIF target genes reveals that some HIF-targets, such as furin, could play a negative role with respect to viral entry. On the other hand, HIF prolyl hydroxylase inhibitors counteract ferroptosis, the process recently implicated in vessel damage during the later stages of COVID-19. Therefore, HIF prolyl hydroxylase inhibitors may serve as a promising treatment of COVID-19 complications, but they are unlikely to aid in the prevention of the initial stages of infection.
Collapse
Affiliation(s)
| | | | - Dmitry M Hushpulian
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.,School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia
| | - Eliot H Kazakov
- Department of Anatomy and Cell Biology, New York Medical College, Valhalla, NY, United States
| | | | - Sergey V Kazakov
- Department of Chemistry and Physical Sciences, Dyson College of Arts and Sciences, Pace University, Pleasantville, NY, United States
| | - Valery I Vechorko
- City Clinical Hospital No 15 Named After O. M. Filatov, Moscow, Russia
| | - Sergey V Nikulin
- Faculty of Biology and Biotechnology, HSE University, Moscow, Russia
| | - Julia A Makarova
- Faculty of Biology and Biotechnology, HSE University, Moscow, Russia
| | - Irina G Gazaryan
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.,Department of Anatomy and Cell Biology, New York Medical College, Valhalla, NY, United States.,Department of Chemistry and Physical Sciences, Dyson College of Arts and Sciences, Pace University, Pleasantville, NY, United States.,Chemical Enzymology Department, M. V. Lomonosov Moscow State University, Moscow, Russia
| |
Collapse
|
8
|
Nikulin SV, Alekseev BY, Sergeeva NS, Karalkin PA, Nezhurina EK, Kirsanova VA, Sviridova IK, Akhmedova SA, Volchenko NN, Bolotina LV, Osipyants AI, Hushpulian DM, Topchiy MA, Asachenko AF, Koval AP, Shcherbo DS, Kiselev VI, Mikhaylenko DS, Schumacher U, Poloznikov AA. Breast cancer organoid model allowed to reveal potentially beneficial combinations of 3,3'-diindolylmethane and chemotherapy drugs. Biochimie 2020; 179:217-227. [PMID: 33098909 DOI: 10.1016/j.biochi.2020.10.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 10/13/2020] [Accepted: 10/19/2020] [Indexed: 02/07/2023]
Abstract
Epigenetic alterations represent promising therapeutic targets in cancer treatment. Recently it was revealed that small molecules have the potential to act as microRNA silencers. Capacity to bind the discrete stem-looped structure of pre-miR-21 and prevent its maturation opens opportunities to utilize such compounds for the prevention of initiation, progression, and chemoresistance of cancer. Molecular simulations performed earlier identified 3,3'-diindolylmethane (DIM) as a potent microRNA-21 antagonist. However, data on DIM and microRNA-21 interplay is controversial, which may be caused by the limitations of the cell lines.
Collapse
Affiliation(s)
- Sergey V Nikulin
- Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, 101000, Russia; P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Boris Ya Alekseev
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Nataliya S Sergeeva
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Pavel A Karalkin
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Elizaveta K Nezhurina
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Valentina A Kirsanova
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Irina K Sviridova
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Suraja A Akhmedova
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Nadezhda N Volchenko
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Larisa V Bolotina
- P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia
| | - Andrey I Osipyants
- School of Biomedicine, Far Eastern Federal University, Vladivostok, 690091, Russia
| | - Dmitry M Hushpulian
- School of Biomedicine, Far Eastern Federal University, Vladivostok, 690091, Russia; Institute of Nanotechnology of Microelectronics, 32A Leninsky Prospekt, Moscow, 119991, Russia
| | - Maxim A Topchiy
- A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, Moscow, 119991, Russia
| | - Andrey F Asachenko
- A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilov str. 28, Moscow, 119991, Russia
| | - Anastasia P Koval
- Molecular Oncology Laboratory, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, 117997, Russia
| | - Dmitry S Shcherbo
- Molecular Oncology Laboratory, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, 117997, Russia
| | - Vsevolod I Kiselev
- National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Moscow, 117997, Russia
| | - Dmitry S Mikhaylenko
- Institute of Molecular Medicine, Biomedical Science and Technology Park, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991, Russia; Research Centre for Medical Genetics, Moscow, 115522, Russia
| | - Udo Schumacher
- Institute of Anatomy and Experimental Morphology, University Medical Center, Hamburg-Eppendorf, Hamburg, 20246, Germany
| | - Andrey A Poloznikov
- Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, 101000, Russia; P. A. Hertsen Moscow Oncology Research Center, Branch of the National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, 125284, Russia.
| |
Collapse
|
9
|
Olloqui-Sariego JL, Zakharova GS, Poloznikov AA, Calvente JJ, Hushpulian DM, Gorton L, Andreu R. Influence of tryptophan mutation on the direct electron transfer of immobilized tobacco peroxidase. Electrochim Acta 2020. [DOI: 10.1016/j.electacta.2020.136465] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
10
|
Poloznikov AA, Nikulin SV, Zakhariants AA, Khristichenko AY, Hushpulian DM, Gazizov IN, Tishkov VI, Gazaryan IG. "Branched Tail" Oxyquinoline Inhibitors of HIF Prolyl Hydroxylase: Early Evaluation of Toxicity and Metabolism Using Liver-on-a-chip. Drug Metab Lett 2019; 13:45-52. [PMID: 30488807 DOI: 10.2174/1872312813666181129100950] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2018] [Revised: 10/18/2018] [Accepted: 11/07/2018] [Indexed: 06/09/2023]
Abstract
BACKGROUND "Branched tail" oxyquinolines, and adaptaquin in particular, are potent HIF prolyl hydroxylase inhibitors showing promising results in in vivo hemorrhagic stroke models. The further improvement of the potency resulted in identification of a number of adaptaquin analogs. Early evaluation of toxicity and metabolism is desired right at the step of lead selection. OBJECTIVE The aim of the study is to characterize the toxicity and metabolism of adaptaquin and its new improved analogs. METHOD Liver-on-a-chip technology with differentiated HepaRG cells followed by LC-MS detection of the studied compounds and metabolites of the P450 substrate-inhibitor panel for CYP2B6, CYP2C9, CYP2C19, and CYP3A4. RESULTS The optimized adaptaquin analogs show no toxicity up to a 100-fold increased range over EC50. The drugs are metabolized by CYP3A4 and CYP2B6 as shown with the use of the cytochrome P450 substrate-inhibitor panel designed and optimized for preclinical evaluation of drugs' in vitro biotransformation on a 3D human histotypical cell model using "liver-on-a-chip" technology. Activation of CYP2B6 with the drugs tested has been observed. A scheme for adaptaquin oxidative conversion is proposed. CONCLUSION The optimized adaptaquin analogs are suitable for further preclinical trials. Activation of CYP2B6 with adaptaquin and its variants points to a potential increase in Tylenol toxicity if administered together.
Collapse
Affiliation(s)
- Andrey A Poloznikov
- Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology, Healthcare Ministry of Russia, 117997 Moscow, Russian Federation
- National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Koroleva, 4, 249036 Obninsk, Russian Federation
| | - Sergey V Nikulin
- Moscow Institute of Physics and Technology, Institutsky lane 9, Dolgoprudny, Moscow region, 141700, Russian Federation
| | - Arpenik A Zakhariants
- Department of Chemical Enzymology, School of Chemistry, M.V. Lomonosov Moscow State University, Moscow 119991, Russian Federation
| | - Anna Y Khristichenko
- Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology, Healthcare Ministry of Russia, 117997 Moscow, Russian Federation
| | - Dmitry M Hushpulian
- Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology, Healthcare Ministry of Russia, 117997 Moscow, Russian Federation
| | - Ildar N Gazizov
- Far Eastern Federal University, Vladivostok, Russian Federation
| | - Vladimir I Tishkov
- Department of Chemical Enzymology, School of Chemistry, M.V. Lomonosov Moscow State University, Moscow 119991, Russian Federation
- Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences. 33, bld. 2 Leninsky Ave., Moscow 119071, Russian Federation
- Innovation and High Technologies MSU Ltd., Tsymlyanskaya 16, Moscow 109599, Russian Federation
| | - Irina G Gazaryan
- Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology, Healthcare Ministry of Russia, 117997 Moscow, Russian Federation
- Department of Chemical Enzymology, School of Chemistry, M.V. Lomonosov Moscow State University, Moscow 119991, Russian Federation
- Department of Anatomy and Cell Biology, New York Medical College, 15 Dana Road, Valhalla, NY 10595, United States
| |
Collapse
|
11
|
Tapias V, Jainuddin S, Ahuja M, Stack C, Elipenahli C, Vignisse J, Gerges M, Starkova N, Xu H, Starkov AA, Bettendorff L, Hushpulian DM, Smirnova NA, Gazaryan IG, Kaidery NA, Wakade S, Calingasan NY, Thomas B, Gibson GE, Dumont M, Beal MF. Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. Hum Mol Genet 2018; 27:2874-2892. [PMID: 29860433 PMCID: PMC6077804 DOI: 10.1093/hmg/ddy201] [Citation(s) in RCA: 49] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2018] [Revised: 04/26/2018] [Accepted: 05/01/2018] [Indexed: 12/21/2022] Open
Abstract
Impaired glucose metabolism, decreased levels of thiamine and its phosphate esters, and reduced activity of thiamine-dependent enzymes, such as pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase and transketolase occur in Alzheimer's disease (AD). Thiamine deficiency exacerbates amyloid beta (Aβ) deposition, tau hyperphosphorylation and oxidative stress. Benfotiamine (BFT) rescued cognitive deficits and reduced Aβ burden in amyloid precursor protein (APP)/PS1 mice. In this study, we examined whether BFT confers neuroprotection against tau phosphorylation and the generation of neurofibrillary tangles (NFTs) in the P301S mouse model of tauopathy. Chronic dietary treatment with BFT increased lifespan, improved behavior, reduced glycated tau, decreased NFTs and prevented death of motor neurons. BFT administration significantly ameliorated mitochondrial dysfunction and attenuated oxidative damage and inflammation. We found that BFT and its metabolites (but not thiamine) trigger the expression of Nrf2/antioxidant response element (ARE)-dependent genes in mouse brain as well as in wild-type but not Nrf2-deficient fibroblasts. Active metabolites were more potent in activating the Nrf2 target genes than the parent molecule BFT. Docking studies showed that BFT and its metabolites (but not thiamine) bind to Keap1 with high affinity. These findings demonstrate that BFT activates the Nrf2/ARE pathway and is a promising therapeutic agent for the treatment of diseases with tau pathology, such as AD, frontotemporal dementia and progressive supranuclear palsy.
Collapse
Affiliation(s)
- Victor Tapias
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Shari Jainuddin
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Manuj Ahuja
- Department of Pharmacology, Toxicology and Neurology, Augusta University, Augusta, GA 30912, USA
| | - Cliona Stack
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Ceyhan Elipenahli
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Julie Vignisse
- Laboratory of Neurophysiology, GIGA-Neurosciences, University of Liege, 4000 Liege, Belgium
| | - Meri Gerges
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Natalia Starkova
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Hui Xu
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Anatoly A Starkov
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Lucien Bettendorff
- Laboratory of Neurophysiology, GIGA-Neurosciences, University of Liege, 4000 Liege, Belgium
| | - Dmitry M Hushpulian
- D. Rogachev Federal Scientific and Clinical Center for Pediatric Hematology, Oncology, and Immunology, 117997 Moscow, Russia
- Veropharm, Abbott EPD, 115088 Moscow, Russia
| | - Natalya A Smirnova
- D. Rogachev Federal Scientific and Clinical Center for Pediatric Hematology, Oncology, and Immunology, 117997 Moscow, Russia
| | - Irina G Gazaryan
- Department of Chemistry and Physical Sciences, Pace University, Pleasantville, NY 10570, USA
- Department of Enzymology, School of Chemistry, 119991 Moscow, Russia
| | - Navneet A Kaidery
- Department of Pharmacology, Toxicology and Neurology, Augusta University, Augusta, GA 30912, USA
| | - Sushama Wakade
- Department of Pharmacology, Toxicology and Neurology, Augusta University, Augusta, GA 30912, USA
| | - Noel Y Calingasan
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - Bobby Thomas
- Department of Pharmacology, Toxicology and Neurology, Augusta University, Augusta, GA 30912, USA
| | - Gary E Gibson
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
- Burke Medical Research Institute, Weill Cornell Medicine, White Plains, NY 10605, USA
| | - Magali Dumont
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| | - M Flint Beal
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA
| |
Collapse
|
12
|
Osipyants AI, Poloznikov AA, Smirnova NA, Hushpulian DM, Khristichenko AY, Chubar TA, Zakhariants AA, Ahuja M, Gaisina IN, Thomas B, Brown AM, Gazaryan IG, Tishkov VI. L-ascorbic acid: A true substrate for HIF prolyl hydroxylase? Biochimie 2017; 147:46-54. [PMID: 29289682 DOI: 10.1016/j.biochi.2017.12.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2017] [Accepted: 12/22/2017] [Indexed: 12/20/2022]
Abstract
L-Ascorbate (L-Asc), but not D-isoascorbate (D-Asc) and N-acetylcysteine (NAC) suppress HIF1 ODD-luc reporter activation induced by various inhibitors of HIF prolyl hydroxylase (PHD). The efficiency of suppression by L-Asc was sensitive to the nature of HIF PHD inhibitor chosen for reporter activation. In particular, the inhibitors developed to compete with alpha-ketoglutarate (αKG), were less sensitive to suppression by the physiological range of L-Asc (40-100 μM) than those having a strong iron chelation motif. Challenging those HIF activators in the reporter system with D-Asc demonstrated that the D-isomer, despite exhibiting the same reducing potency with respect to ferric iron, had almost no effect compared to L-Asc. Similarly, no effect on reporter activation was observed with cell-permeable reducing agent NAC up to 1 mM. Docking of L-Asc and D-Asc acid into the HIF PHD2 crystal structure showed interference of Tyr310 with respect to D-Asc. This suggests that L-Asc is not merely a reducing agent preventing enzyme inactivation. Rather, the overall results identify L-Asc as a co-substrate of HIF PHD that may compete for the binding site of αKG in the enzyme active center. This conclusion is in agreement with the results obtained recently in cell-based systems for TET enzymes and jumonji histone demethylases, where L-Asc has been proposed to act as a co-substrate and not as a reducing agent preventing enzyme inactivation.
Collapse
Affiliation(s)
- Andrey I Osipyants
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation
| | - Andrey A Poloznikov
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation.
| | - Natalya A Smirnova
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation
| | - Dmitry M Hushpulian
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation
| | - Anna Yu Khristichenko
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation
| | - Tatiana A Chubar
- Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation
| | - Arpenik A Zakhariants
- Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation
| | - Manuj Ahuja
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
| | - Irina N Gaisina
- Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
| | - Bobby Thomas
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
| | - Abe M Brown
- Department of Anatomy and Cell Biology, New York Medical College, 15 Dana Road, Valhalla, NY 10595, USA
| | - Irina G Gazaryan
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117997, Moscow, Russian Federation; Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation; Department of Anatomy and Cell Biology, New York Medical College, 15 Dana Road, Valhalla, NY 10595, USA
| | - Vladimir I Tishkov
- Department of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, 119992, Russian Federation; Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences. 33, bld. 2 Leninsky Ave., Moscow 119071, Russian Federation; Innovations and High Technologies MSU Ltd, Tsymlyanskaya, 16, of 96, Moscow, 109599, Russian Federation
| |
Collapse
|
13
|
Smirnova NA, Kaidery NA, Hushpulian DM, Rakhman II, Poloznikov AA, Tishkov VI, Karuppagounder SS, Gaisina IN, Pekcec A, Leyen KV, Kazakov SV, Yang L, Thomas B, Ratan RR, Gazaryan IG. Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson's Disease. Aging Dis 2016; 7:745-762. [PMID: 28053825 PMCID: PMC5201116 DOI: 10.14336/ad.2016.0505] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2016] [Accepted: 05/05/2016] [Indexed: 12/30/2022] Open
Abstract
Flavonoids are known to trigger the intrinsic genetic adaptive programs to hypoxic or oxidative stress via estrogen receptor engagement or upstream kinase activation. To reveal specific structural requirements for direct stabilization of the transcription factors responsible for triggering the antihypoxic and antioxidant programs, we studied flavones, isoflavones and catechols including dihydroxybenzoate, didox, levodopa, and nordihydroguaiaretic acid (NDGA), using novel luciferase-based reporters specific for the first step in HIF1 or Nrf2 protein stabilization. Distinct structural requirements for either transcription factor stabilization have been found: as expected, these requirements for activation of HIF ODD-luc reporter correlate with in silico binding to HIF prolyl hydroxylase. By contrast, stabilization of Nrf2 requires the presence of 3,4-dihydroxy- (catechol) groups. Thus, only some but not all flavonoids are direct activators of the hypoxic and antioxidant genetic programs. NDGA from the Creosote bush resembles the best flavonoids in their ability to directly stabilize HIF1 and Nrf2 and is superior with respect to LOX inhibition thus favoring this compound over others. Given much higher bioavailability and stability of NDGA than any flavonoid, NDGA has been tested in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-animal model of Parkinson's Disease and demonstrated neuroprotective effects.
Collapse
Affiliation(s)
- Natalya A Smirnova
- 1Burke Medical Research Institute, Weill Medical College of Cornell University, White Plains, NY 10605, USA; 2D. Rogachev Federal Scientific and Clinical Center for Pediatric Hematology, Oncology, and Immunology, Moscow 117997, Russia
| | - Navneet Ammal Kaidery
- 3Departments of Pharmacology, Toxicology & Neurology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
| | - Dmitry M Hushpulian
- 2D. Rogachev Federal Scientific and Clinical Center for Pediatric Hematology, Oncology, and Immunology, Moscow 117997, Russia; 4ValentaPharm, Moscow 119530, Russia
| | - Ilay I Rakhman
- 1Burke Medical Research Institute, Weill Medical College of Cornell University, White Plains, NY 10605, USA
| | - Andrey A Poloznikov
- 2D. Rogachev Federal Scientific and Clinical Center for Pediatric Hematology, Oncology, and Immunology, Moscow 117997, Russia
| | - Vladimir I Tishkov
- 5Department of Chemical Enzymology, Moscow State University, Moscow 119992, Russia
| | - Saravanan S Karuppagounder
- 1Burke Medical Research Institute, Weill Medical College of Cornell University, White Plains, NY 10605, USA
| | - Irina N Gaisina
- 6Department of Medicinal Chemistry and Pharmacology, University of Illinois at Chicago, Chicago, IL 60612, USA
| | - Anton Pekcec
- 7Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
| | - Klaus Van Leyen
- 7Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
| | - Sergey V Kazakov
- 8Department of Chemistry and Physical Sciences, Dyson College, Pace University, Pleasantville, NY 10570, USA
| | - Lichuan Yang
- 3Departments of Pharmacology, Toxicology & Neurology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
| | - Bobby Thomas
- 3Departments of Pharmacology, Toxicology & Neurology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
| | - Rajiv R Ratan
- 1Burke Medical Research Institute, Weill Medical College of Cornell University, White Plains, NY 10605, USA
| | - Irina G Gazaryan
- 1Burke Medical Research Institute, Weill Medical College of Cornell University, White Plains, NY 10605, USA; 5Department of Chemical Enzymology, Moscow State University, Moscow 119992, Russia; 8Department of Chemistry and Physical Sciences, Dyson College, Pace University, Pleasantville, NY 10570, USA
| |
Collapse
|
14
|
Olloqui-Sariego JL, Zakharova GS, Poloznikov AA, Calvente JJ, Hushpulian DM, Gorton L, Andreu R. Fenton-like Inactivation of Tobacco Peroxidase Electrocatalysis at Negative Potentials. ACS Catal 2016. [DOI: 10.1021/acscatal.6b01839] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- José Luis Olloqui-Sariego
- Department
of Physical Chemistry, University of Sevilla, Profesor García González
1, 41012 Sevilla, Spain
| | - Galina S. Zakharova
- D. Rogachev center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mashela strasse, Moscow 117997, Russia
| | - Andrey A. Poloznikov
- D. Rogachev center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mashela strasse, Moscow 117997, Russia
| | - Juan José Calvente
- Department
of Physical Chemistry, University of Sevilla, Profesor García González
1, 41012 Sevilla, Spain
| | - Dmitry M. Hushpulian
- D. Rogachev center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mashela strasse, Moscow 117997, Russia
| | - Lo Gorton
- Department
of Biochemistry and Structural Biology, Lund University, P.O. Box 124, 221 00 Lund, Sweden
| | - Rafael Andreu
- Department
of Physical Chemistry, University of Sevilla, Profesor García González
1, 41012 Sevilla, Spain
| |
Collapse
|
15
|
Olloqui-Sariego JL, Zakharova GS, Poloznikov AA, Calvente JJ, Hushpulian DM, Gorton L, Andreu R. Interprotein Coupling Enhances the Electrocatalytic Efficiency of Tobacco Peroxidase Immobilized at a Graphite Electrode. Anal Chem 2015; 87:10807-14. [PMID: 26437673 DOI: 10.1021/acs.analchem.5b01710] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Covalent immobilization of enzymes at electrodes via amide bond formation is usually carried out by a two-step protocol, in which surface carboxylic groups are first activated with the corresponding cross-coupling reagents and then reacted with protein amine groups. Herein, it is shown that a modification of the above protocol, involving the simultaneous incubation of tobacco peroxidase and the pyrolytic graphite electrode with the cross-coupling reagents produces higher and more stable electrocatalytic currents than those obtained with either physically adsorbed enzymes or covalently immobilized enzymes according to the usual immobilization protocol. The remarkably improved electrocatalytic properties of the present peroxidase biosensor that operates in the 0.3 V ≤ E ≤ 0.8 V (vs SHE) potential range can be attributed to both an efficient electronic coupling between tobacco peroxidase and graphite and to the formation of intra- and intermolecular amide bonds that stabilize the protein structure and improve the percentage of anchoring groups that provide an adequate orientation for electron exchange with the electrode. The optimized tobacco peroxidase sensor exhibits a working concentration range of 10-900 μM, a sensitivity of 0.08 A M(-1) cm(-2) (RSD 0.05), a detection limit of 2 μM (RSD 0.09), and a good long-term stability, as long as it operates at low temperature. These parameter values are among the best reported so far for a peroxidase biosensor operating under simple direct electron transfer conditions.
Collapse
Affiliation(s)
- José Luis Olloqui-Sariego
- Department of Physical Chemistry, University of Sevilla , Profesor García González 1, 41012, Sevilla, Spain
| | - Galina S Zakharova
- A.N. Bach Institute of Biochemistry, Russian Academy of Sciences , Leninsky Prospect 33/2, Moscow, 119071, Russia
| | - Andrey A Poloznikov
- Department of Chemistry, Lomonosov Moscow State University , Vorob'evy Gory 1, Moscow, 119991, Russia
| | - Juan José Calvente
- Department of Physical Chemistry, University of Sevilla , Profesor García González 1, 41012, Sevilla, Spain
| | - Dmitry M Hushpulian
- Department of Chemistry, Lomonosov Moscow State University , Vorob'evy Gory 1, Moscow, 119991, Russia
| | - Lo Gorton
- Department of Biochemistry and Structural Biology, University of Lund, Kemicentrum , Box 118, 221 00, Lund, Sweden
| | - Rafael Andreu
- Department of Physical Chemistry, University of Sevilla , Profesor García González 1, 41012, Sevilla, Spain
| |
Collapse
|
16
|
Poloznikov AA, Zakharova GS, Chubar TA, Hushpulian DM, Tishkov VI, Gazaryan IG. Site-directed mutagenesis of tobacco anionic peroxidase: Effect of additional aromatic amino acids on stability and activity. Biochimie 2015; 115:71-7. [PMID: 25957835 DOI: 10.1016/j.biochi.2015.04.021] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Accepted: 04/27/2015] [Indexed: 11/19/2022]
Abstract
Tobacco anionic peroxidase (TOP) is known to effectively catalyze luminol oxidation without enhancers, in contrast to horseradish peroxidase (HRP). To pursue structure-activity relationship studies for TOP, two amino acids have been chosen for mutation, namely Thr151, close to the heme plane, and Phe140 at the entrance to the active site pocket. Three mutant forms TOP F140Y, T151W and F140Y/T151W have been expressed in Escherichia coli, and reactivated to yield active enzymes. Single-point mutations introducing additional aromatic amino acid residues at the surface of TOP exhibit a significant effect on the enzyme catalytic activity and stability as judged by the results of steady-state and transient kinetics studies. TOP T151W is up to 4-fold more active towards a number of aromatic substrates including luminol, whereas TOP F140Y is 2-fold more stable against thermal inactivation and 8-fold more stable in the reaction course. These steady-state observations have been rationalized with the help of transient kinetic studies on the enzyme reaction with hydrogen peroxide in a single turnover regime. The stopped-flow data reveal (a) an increased stability of F140Y Compound I towards hydrogen peroxide, and thus, a higher operational stability as compared to the wild-type enzyme, and (b) a lesser leakage of oxidative equivalents from TOP T151W Compound I resulting in the increased catalytic activity. The results obtained show that TOP unique properties can be further improved for practical applications by site-directed mutagenesis.
Collapse
Affiliation(s)
- A A Poloznikov
- Chemistry Faculty, Lomonosov Moscow State University, 119992 Moscow, Russia; Innovations and High Technologies MSU Ltd, 109559 Moscow, Russia.
| | - G S Zakharova
- Innovations and High Technologies MSU Ltd, 109559 Moscow, Russia; A.N. Bach Institute of Biochemistry, RAS, 119071 Moscow, Russia
| | - T A Chubar
- Chemistry Faculty, Lomonosov Moscow State University, 119992 Moscow, Russia
| | - D M Hushpulian
- Chemistry Faculty, Lomonosov Moscow State University, 119992 Moscow, Russia; Innovations and High Technologies MSU Ltd, 109559 Moscow, Russia
| | - V I Tishkov
- Chemistry Faculty, Lomonosov Moscow State University, 119992 Moscow, Russia; Innovations and High Technologies MSU Ltd, 109559 Moscow, Russia; A.N. Bach Institute of Biochemistry, RAS, 119071 Moscow, Russia
| | - I G Gazaryan
- Chemistry Faculty, Lomonosov Moscow State University, 119992 Moscow, Russia; Burke Medical Research Institute, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 785 Mamaroneck Ave, White Plains, NY 10605, USA
| |
Collapse
|
17
|
Smirnova NA, Hushpulian DM, Speer RE, Gaisina IN, Ratan RR, Gazaryan IG. Catalytic mechanism and substrate specificity of HIF prolyl hydroxylases. Biochemistry (Mosc) 2013; 77:1108-19. [PMID: 23157291 DOI: 10.1134/s0006297912100033] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
This review describes the catalytic mechanism, substrate specificity, and structural peculiarities of alpha-ketoglutarate dependent nonheme iron dioxygenases catalyzing prolyl hydroxylation of hypoxia-inducible factor (HIF). Distinct localization and regulation of three isoforms of HIF prolyl hydroxylases suggest their different roles in cells. The recent identification of novel substrates other than HIF, namely β2-adrenergic receptor and the large subunit of RNA polymerase II, places these enzymes in the focus of drug development efforts aimed at development of isoform-specific inhibitors. The challenges and prospects of designing isoform-specific inhibitors are discussed.
Collapse
Affiliation(s)
- N A Smirnova
- Burke Medical Research Institute, White Plains, NY 10605, USA.
| | | | | | | | | | | |
Collapse
|
18
|
Kaidery NA, Banerjee R, Yang L, Smirnova NA, Hushpulian DM, Liby KT, Williams CR, Yamamoto M, Kensler TW, Ratan RR, Sporn MB, Beal MF, Gazaryan IG, Thomas B. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease. Antioxid Redox Signal 2013; 18:139-57. [PMID: 22746536 PMCID: PMC3514006 DOI: 10.1089/ars.2011.4491] [Citation(s) in RCA: 130] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
UNLABELLED Although the etiology of Parkinson's disease (PD) remains unclear, ample empirical evidence suggests that oxidative stress is a major player in the development of PD and in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Nuclear factor E2-related factor 2 (Nrf2) is a redox-sensitive transcription factor that upregulates a battery of antioxidant response element (ARE)-driven antioxidative and cytoprotective genes that defend against oxidative stress. AIMS We evaluated whether the strategy of activation of Nrf2 and its downstream network of cytoprotective genes with small molecule synthetic triterpenoids (TP) attenuate MPTP-induced PD in mice. RESULTS We show that synthetic TP are thus far the most potent and direct activators of the Nrf2 pathway using a novel Neh2-luciferase reporter. They upregulate several cytoprotective genes, including those involved in glutathione biosynthesis in vitro. Oral administration of TP that were structurally modified to penetrate the brain-induced messenger RNA and protein levels for a battery of Nrf2-dependent cytoprotective genes reduced MPTP-induced oxidative stress and inflammation, and ameliorated dopaminergic neurotoxicity in mice. The neuroprotective effect of these TP against MPTP neurotoxicity was dependent on Nrf2, since treatment with TP in Nrf2 knockout mice failed to block against MPTP neurotoxicity and induce Nrf2-dependent cytoprotective genes. INNOVATION Extremely potent synthetic TP that are direct activators of the Nrf2 pathway block dopaminergic neurodegeneration in the MPTP mouse model of PD. CONCLUSION Our results indicate that activation of Nrf2/antioxidant response element (ARE) signaling by synthetic TP is directly associated with their neuroprotective effects against MPTP neurotoxicity and suggest that targeting the Nrf2/ARE pathway is a promising approach for therapeutic intervention in PD.
Collapse
Affiliation(s)
- Navneet Ammal Kaidery
- Department of Pharmacology & Toxicology, Georgia Health Sciences University, Augusta, GA 30912, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Hushpulian DM, Savitski PA, Rojkova AM, Chubar TA, Fechina VA, Sakharov IY, Lagrimini LM, Tishkov VI, Gazaryan IG. Expression and Refolding of Tobacco Anionic Peroxidase from E. coli Inclusion Bodies. Biochemistry (Moscow) 2003; 68:1189-94. [PMID: 14640960 DOI: 10.1023/b:biry.0000009132.45842.93] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Coding DNA of the tobacco anionic peroxidase gene was cloned in pET40b vector. The problem of 11 arginine codons, rare in procaryotes, in the tobacco peroxidase gene was solved using E. coli BL21(DE3) Codon Plus strain. The expression level of the tobacco apo-peroxidase in the above strain was approximately 40% of the total E. coli protein. The tobacco peroxidase refolding was optimized based on the earlier developed protocol for horseradish peroxidase. The reactivation yield of recombinant tobacco enzyme was about 7% with the specific activity of 1100-1200 U/mg towards 2,2;-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (ABTS). It was shown that the reaction of ABTS oxidation by hydrogen peroxide catalyzed by recombinant tobacco peroxidase proceeds via the ping-pong kinetic mechanism as for the native enzyme. In the presence of calcium ions, the recombinant peroxidase exhibits a 2.5-fold decrease in the second order rate constant for hydrogen peroxide and 1.5-fold decrease for ABTS. Thus, calcium ions have an inhibitory effect on the recombinant enzyme like that observed earlier for the native tobacco peroxidase. The data demonstrate that the oligosaccharide part of the enzyme has no effect on the kinetic properties and calcium inhibition of tobacco peroxidase.
Collapse
Affiliation(s)
- D M Hushpulian
- Department of Chemical Enzymology, Faculty of Chemistry, Lomonosov Moscow State University, Moscow, 119992, Russia.
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Hushpulian DM, Fechina VA, Kazakov SV, Sakharov IY, Gazaryan IG. Non-enzymatic interaction of reaction products and substrates in peroxidase catalysis. Biochemistry (Mosc) 2003; 68:1006-11. [PMID: 14606944 DOI: 10.1023/a:1026016730127] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
A quantitative approach for estimation of the non-enzymatic interaction between ammonium 2,2;-azino-bis(3-ethylbenzthiazoline-6-sulfonate) (ABTS) oxidation product and a poorly oxidized substrate was developed using a system including tobacco peroxidase, a mediator substrate (ABTS), and a second substrate. The approach is based on the establishment of a pseudo-steady-state concentration of the ABTS oxidation product in the course of co-oxidation with a poor substrate. A mathematical description of the experimental curve shape has been proposed to linearize the kinetic data and estimate the rate constant for such non-enzymatic interaction. The rate constants calculated from the steady-state kinetics for the non-enzymatic interaction of ABTS oxidation product with phenol and resorcinol were 360 +/- 40 and 770 +/- 60 M(-1).sec(-1), respectively. The values obtained have the same order of magnitude as the rate constant for ABTS oxidation product interaction with veratryl alcohol, calculated from electrochemical measurements (170 M(-1).sec(-1)) by Donal Leech's group. However, the kinetic curves for co-oxidation of ABTS and veratryl alcohol catalyzed by tobacco peroxidase exhibit a pronounced lag-period, which either points to the high rate of the non-enzymatic interaction between ABTS oxidation product and veratryl alcohol and thus, contradicts the electrochemical calculations, or indicates an enzymatic nature of the co-oxidation phenomenon in this particular case.
Collapse
Affiliation(s)
- D M Hushpulian
- Department of Chemical Enzymology, Faculty of Chemistry, Lomonosov Moscow State University, Moscow 119992, Russia
| | | | | | | | | |
Collapse
|